Copyright
©The Author(s) 2021.
World J Gastroenterol. Aug 7, 2021; 27(29): 4913-4928
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4913
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4913
Figure 3 Receiver operating characteristic curves and corresponding areas under the curve of models to predict non-alcoholic fatty liver disease-associated steatosis.
ROC: Receiver operating characteristic; CI: Confidence interval.
- Citation: Pereira ENGDS, Paula DP, Araujo BP, Fonseca MJMD, Diniz MFHS, Daliry A, Griep RH. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World J Gastroenterol 2021; 27(29): 4913-4928
- URL: https://www.wjgnet.com/1007-9327/full/v27/i29/4913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i29.4913